MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Progressive Supranuclear Palsy : About one case at the Neurology Department – Dakar

L. Belarabi, K. Toure, M. Ndiaye (Dakar, Senegal)

Meeting: 2017 International Congress

Abstract Number: 232

Keywords: Progressive supranuclear palsy(PSP)

Session Information

Date: Monday, June 5, 2017

Session Title: Parkinsonism, MSA, PSP (Secondary and Parkinsonism-Plus)

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: We report an observation of a case received at the consultation in the Neurology Department of National Teaching Hospital Fann.

Background: Progressive supranuclear palsy (PSP) is a neurodegenerative disease (see the image below) whose characteristics include supranuclear, initially vertical, gaze dysfunction accompanied by extrapyramidal symptoms and cognitive dysfunction. The disease usually develops after the sixth decade of life. and the diagnosis is purely clinical.

Methods: Patient of 67 years , without specific medical history , which has since 6 months: falls, difficulty maintaining the sitting position , execution of daily activities ( eating, bathing … ) , urination, and alteration of mood behavior with loss of interest in pleasurable activities.

The patient was in fairly good condition, and has an extrapyramidal syndrome without tremors, lateral gaze palsy, and a frontal syndrome. His  MMSE’ score was 14/30.

The MRI shows a bi-frontal atrophy with shrinkage of the midbrain.

Results: The treatment with L-dopa was inefficient with no improvement. 

Conclusions: The diagnosis of progressive supra nuclear palsy is purely clinical. Key features typically develop over time. Physical therapy and rehabilitation medicine involvement may help maximize ambulation safety and facilitate instruction in the use of a walker, wheelchair, or other aids.

To cite this abstract in AMA style:

L. Belarabi, K. Toure, M. Ndiaye. Progressive Supranuclear Palsy : About one case at the Neurology Department – Dakar [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/progressive-supranuclear-palsy-about-one-case-at-the-neurology-department-dakar/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/progressive-supranuclear-palsy-about-one-case-at-the-neurology-department-dakar/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley